Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothione for Mild to Moderate COVID-19
NCT04742725Phase 2Completed
- Sponsor
- Prothione
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Prothione in coronavirus disease 2019 (COVID-19), sponsored by Prothione. Started May 2021; status: completed.
02
Drugs
Prothione
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04742725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742725.